Cargando…
Tauroursodeoxycholic acid functions as a critical effector mediating insulin sensitization of metformin in obese mice
Metformin is widely used to surmount insulin resistance (IR) and type 2 diabetes. Accumulating evidence suggests that metformin may improve IR through regulating gut microbiota and bile acids. However, the underlying mechanisms remain unclear. Our metabolomic analysis showed that metformin significa...
Autores principales: | Zhang, Ya, Cheng, Yang, Liu, Jian, Zuo, Jihui, Yan, Liping, Thring, Ronald W., Ba, Xueqing, Qi, Dake, Wu, Mingjiang, Gao, Yitian, Tong, Haibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493383/ https://www.ncbi.nlm.nih.gov/pubmed/36148770 http://dx.doi.org/10.1016/j.redox.2022.102481 |
Ejemplares similares
-
Tauroursodeoxycholic Acid May Improve Liver and Muscle but Not Adipose Tissue Insulin Sensitivity in Obese Men and Women
por: Kars, Marleen, et al.
Publicado: (2010) -
Mechanisms of tauroursodeoxycholate-mediated inhibition of apoptosis
por: Sommerfeld, Annika, et al.
Publicado: (2014) -
Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis
por: Ahn, Tae-Keun, et al.
Publicado: (2020) -
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
por: Elia, A. E., et al.
Publicado: (2015) -
Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex
por: Feng, Rui, et al.
Publicado: (2018)